Now that Pacific Biosciences has broken through the $1 level that avoids Nasdaq delisting for now, we can focus on what might be ahead: the near-term path to cash flow breakeven. PacBio’s ...

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, has been gaining from its continued product development. The optimism, led by decent first-quarter results, is expected to ...

Sequencing is being carried out on 1,000 cell lines using PacBio’s Kinnex RNA kits and Revio long-read platform, with each sample expected to yield around 10 million full-length transcript reads.

MENLO PARK, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2025 financial results on ...

PacBio joins the 1000 Genomes Long Read Sequencing Project, contributing long-read transcriptome data for approximately 1,000 samples.

What Happened? Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 7.4% in the afternoon session after the company announced it had joined the 1000 Genomes Long Read ...

Multinational maneuvers are the new normal as the U.S. and its allies prepare for a possible confrontation with China over Taiwan.